Report cover image

Global Intravenous Nutritional Product Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 204 Pages
SKU # APRC20283233

Description

Summary

According to APO Research, The global Intravenous Nutritional Product market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Intravenous Nutritional Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravenous Nutritional Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Intravenous Nutritional Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Intravenous Nutritional Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Intravenous Nutritional Product include Xi'an Libang Pharmaceutical, Weixinkang, B. Braun, Baxter, Otsuka Pharmaceutical, Lummy, Lionco Pharmaceutical, King York and Kelun Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Intravenous Nutritional Product, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Intravenous Nutritional Product, also provides the revenue of main regions and countries. Of the upcoming market potential for Intravenous Nutritional Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Nutritional Product revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Intravenous Nutritional Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Intravenous Nutritional Product revenue, projected growth trends, production technology, application and end-user industry.

Intravenous Nutritional Product Segment by Company

Xi'an Libang Pharmaceutical
Weixinkang
B. Braun
Baxter
Otsuka Pharmaceutical
Lummy
Lionco Pharmaceutical
King York
Kelun Pharma
JW Pharmaceutical
Haisco Pharmaceutical Group
Grifols
Grand Life Sciences
Fresenius Kabi
Cisen
China Meheco Kangli
Biokin Pharmaceutical
BBCA Pharmaceutical
Baizheng Pharmaceutical
Aguettant
Intravenous Nutritional Product Segment by Type

Amino Acid
Alanyl-Glutamine
Heat and Fat Emulsion
Trace Elements
Vitamins
Intravenous Nutritional Product Segment by Application

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Others
Intravenous Nutritional Product Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Nutritional Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Nutritional Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Nutritional Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Intravenous Nutritional Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Intravenous Nutritional Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Nutritional Product revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

204 Pages
1 Market Overview
1.1 Product Definition
1.2 Intravenous Nutritional Product Market by Type
1.2.1 Global Intravenous Nutritional Product Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Amino Acid
1.2.3 Alanyl-Glutamine
1.2.4 Heat and Fat Emulsion
1.2.5 Trace Elements
1.2.6 Vitamins
1.3 Intravenous Nutritional Product Market by Application
1.3.1 Global Intravenous Nutritional Product Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Intravenous Nutritional Product Market Dynamics
2.1 Intravenous Nutritional Product Industry Trends
2.2 Intravenous Nutritional Product Industry Drivers
2.3 Intravenous Nutritional Product Industry Opportunities and Challenges
2.4 Intravenous Nutritional Product Industry Restraints
3 Global Growth Perspective
3.1 Global Intravenous Nutritional Product Market Perspective (2020-2031)
3.2 Global Intravenous Nutritional Product Growth Trends by Region
3.2.1 Global Intravenous Nutritional Product Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Intravenous Nutritional Product Market Size by Region (2020-2025)
3.2.3 Global Intravenous Nutritional Product Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Intravenous Nutritional Product Revenue by Players
4.1.1 Global Intravenous Nutritional Product Revenue by Players (2020-2025)
4.1.2 Global Intravenous Nutritional Product Revenue Market Share by Players (2020-2025)
4.1.3 Global Intravenous Nutritional Product Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Intravenous Nutritional Product Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Intravenous Nutritional Product Key Players Headquarters & Area Served
4.4 Global Intravenous Nutritional Product Players, Product Type & Application
4.5 Global Intravenous Nutritional Product Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Intravenous Nutritional Product Market CR5 and HHI
4.6.3 2024 Intravenous Nutritional Product Tier 1, Tier 2, and Tier 3
5 Intravenous Nutritional Product Market Size by Type
5.1 Global Intravenous Nutritional Product Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Intravenous Nutritional Product Revenue by Type (2020-2031)
5.3 Global Intravenous Nutritional Product Revenue Market Share by Type (2020-2031)
6 Intravenous Nutritional Product Market Size by Application
6.1 Global Intravenous Nutritional Product Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Intravenous Nutritional Product Revenue by Application (2020-2031)
6.3 Global Intravenous Nutritional Product Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Xi'an Libang Pharmaceutical
7.1.1 Xi'an Libang Pharmaceutical Comapny Information
7.1.2 Xi'an Libang Pharmaceutical Business Overview
7.1.3 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.1.4 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.1.5 Xi'an Libang Pharmaceutical Recent Developments
7.2 Weixinkang
7.2.1 Weixinkang Comapny Information
7.2.2 Weixinkang Business Overview
7.2.3 Weixinkang Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.2.4 Weixinkang Intravenous Nutritional Product Product Portfolio
7.2.5 Weixinkang Recent Developments
7.3 B. Braun
7.3.1 B. Braun Comapny Information
7.3.2 B. Braun Business Overview
7.3.3 B. Braun Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.3.4 B. Braun Intravenous Nutritional Product Product Portfolio
7.3.5 B. Braun Recent Developments
7.4 Baxter
7.4.1 Baxter Comapny Information
7.4.2 Baxter Business Overview
7.4.3 Baxter Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.4.4 Baxter Intravenous Nutritional Product Product Portfolio
7.4.5 Baxter Recent Developments
7.5 Otsuka Pharmaceutical
7.5.1 Otsuka Pharmaceutical Comapny Information
7.5.2 Otsuka Pharmaceutical Business Overview
7.5.3 Otsuka Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.5.4 Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.5.5 Otsuka Pharmaceutical Recent Developments
7.6 Lummy
7.6.1 Lummy Comapny Information
7.6.2 Lummy Business Overview
7.6.3 Lummy Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.6.4 Lummy Intravenous Nutritional Product Product Portfolio
7.6.5 Lummy Recent Developments
7.7 Lionco Pharmaceutical
7.7.1 Lionco Pharmaceutical Comapny Information
7.7.2 Lionco Pharmaceutical Business Overview
7.7.3 Lionco Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.7.4 Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.7.5 Lionco Pharmaceutical Recent Developments
7.8 King York
7.8.1 King York Comapny Information
7.8.2 King York Business Overview
7.8.3 King York Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.8.4 King York Intravenous Nutritional Product Product Portfolio
7.8.5 King York Recent Developments
7.9 Kelun Pharma
7.9.1 Kelun Pharma Comapny Information
7.9.2 Kelun Pharma Business Overview
7.9.3 Kelun Pharma Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.9.4 Kelun Pharma Intravenous Nutritional Product Product Portfolio
7.9.5 Kelun Pharma Recent Developments
7.10 JW Pharmaceutical
7.10.1 JW Pharmaceutical Comapny Information
7.10.2 JW Pharmaceutical Business Overview
7.10.3 JW Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.10.4 JW Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.10.5 JW Pharmaceutical Recent Developments
7.11 Haisco Pharmaceutical Group
7.11.1 Haisco Pharmaceutical Group Comapny Information
7.11.2 Haisco Pharmaceutical Group Business Overview
7.11.3 Haisco Pharmaceutical Group Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.11.4 Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio
7.11.5 Haisco Pharmaceutical Group Recent Developments
7.12 Grifols
7.12.1 Grifols Comapny Information
7.12.2 Grifols Business Overview
7.12.3 Grifols Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.12.4 Grifols Intravenous Nutritional Product Product Portfolio
7.12.5 Grifols Recent Developments
7.13 Grand Life Sciences
7.13.1 Grand Life Sciences Comapny Information
7.13.2 Grand Life Sciences Business Overview
7.13.3 Grand Life Sciences Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.13.4 Grand Life Sciences Intravenous Nutritional Product Product Portfolio
7.13.5 Grand Life Sciences Recent Developments
7.14 Fresenius Kabi
7.14.1 Fresenius Kabi Comapny Information
7.14.2 Fresenius Kabi Business Overview
7.14.3 Fresenius Kabi Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.14.4 Fresenius Kabi Intravenous Nutritional Product Product Portfolio
7.14.5 Fresenius Kabi Recent Developments
7.15 Cisen
7.15.1 Cisen Comapny Information
7.15.2 Cisen Business Overview
7.15.3 Cisen Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.15.4 Cisen Intravenous Nutritional Product Product Portfolio
7.15.5 Cisen Recent Developments
7.16 China Meheco Kangli
7.16.1 China Meheco Kangli Comapny Information
7.16.2 China Meheco Kangli Business Overview
7.16.3 China Meheco Kangli Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.16.4 China Meheco Kangli Intravenous Nutritional Product Product Portfolio
7.16.5 China Meheco Kangli Recent Developments
7.17 Biokin Pharmaceutical
7.17.1 Biokin Pharmaceutical Comapny Information
7.17.2 Biokin Pharmaceutical Business Overview
7.17.3 Biokin Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.17.4 Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.17.5 Biokin Pharmaceutical Recent Developments
7.18 BBCA Pharmaceutical
7.18.1 BBCA Pharmaceutical Comapny Information
7.18.2 BBCA Pharmaceutical Business Overview
7.18.3 BBCA Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.18.4 BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.18.5 BBCA Pharmaceutical Recent Developments
7.19 Baizheng Pharmaceutical
7.19.1 Baizheng Pharmaceutical Comapny Information
7.19.2 Baizheng Pharmaceutical Business Overview
7.19.3 Baizheng Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.19.4 Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio
7.19.5 Baizheng Pharmaceutical Recent Developments
7.20 Aguettant
7.20.1 Aguettant Comapny Information
7.20.2 Aguettant Business Overview
7.20.3 Aguettant Intravenous Nutritional Product Revenue and Gross Margin (2020-2025)
7.20.4 Aguettant Intravenous Nutritional Product Product Portfolio
7.20.5 Aguettant Recent Developments
8 North America
8.1 North America Intravenous Nutritional Product Revenue (2020-2031)
8.2 North America Intravenous Nutritional Product Revenue by Type (2020-2031)
8.2.1 North America Intravenous Nutritional Product Revenue by Type (2020-2025)
8.2.2 North America Intravenous Nutritional Product Revenue by Type (2026-2031)
8.3 North America Intravenous Nutritional Product Revenue Share by Type (2020-2031)
8.4 North America Intravenous Nutritional Product Revenue by Application (2020-2031)
8.4.1 North America Intravenous Nutritional Product Revenue by Application (2020-2025)
8.4.2 North America Intravenous Nutritional Product Revenue by Application (2026-2031)
8.5 North America Intravenous Nutritional Product Revenue Share by Application (2020-2031)
8.6 North America Intravenous Nutritional Product Revenue by Country
8.6.1 North America Intravenous Nutritional Product Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Intravenous Nutritional Product Revenue by Country (2020-2025)
8.6.3 North America Intravenous Nutritional Product Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Intravenous Nutritional Product Revenue (2020-2031)
9.2 Europe Intravenous Nutritional Product Revenue by Type (2020-2031)
9.2.1 Europe Intravenous Nutritional Product Revenue by Type (2020-2025)
9.2.2 Europe Intravenous Nutritional Product Revenue by Type (2026-2031)
9.3 Europe Intravenous Nutritional Product Revenue Share by Type (2020-2031)
9.4 Europe Intravenous Nutritional Product Revenue by Application (2020-2031)
9.4.1 Europe Intravenous Nutritional Product Revenue by Application (2020-2025)
9.4.2 Europe Intravenous Nutritional Product Revenue by Application (2026-2031)
9.5 Europe Intravenous Nutritional Product Revenue Share by Application (2020-2031)
9.6 Europe Intravenous Nutritional Product Revenue by Country
9.6.1 Europe Intravenous Nutritional Product Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Intravenous Nutritional Product Revenue by Country (2020-2025)
9.6.3 Europe Intravenous Nutritional Product Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Intravenous Nutritional Product Revenue (2020-2031)
10.2 China Intravenous Nutritional Product Revenue by Type (2020-2031)
10.2.1 China Intravenous Nutritional Product Revenue by Type (2020-2025)
10.2.2 China Intravenous Nutritional Product Revenue by Type (2026-2031)
10.3 China Intravenous Nutritional Product Revenue Share by Type (2020-2031)
10.4 China Intravenous Nutritional Product Revenue by Application (2020-2031)
10.4.1 China Intravenous Nutritional Product Revenue by Application (2020-2025)
10.4.2 China Intravenous Nutritional Product Revenue by Application (2026-2031)
10.5 China Intravenous Nutritional Product Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Intravenous Nutritional Product Revenue (2020-2031)
11.2 Asia Intravenous Nutritional Product Revenue by Type (2020-2031)
11.2.1 Asia Intravenous Nutritional Product Revenue by Type (2020-2025)
11.2.2 Asia Intravenous Nutritional Product Revenue by Type (2026-2031)
11.3 Asia Intravenous Nutritional Product Revenue Share by Type (2020-2031)
11.4 Asia Intravenous Nutritional Product Revenue by Application (2020-2031)
11.4.1 Asia Intravenous Nutritional Product Revenue by Application (2020-2025)
11.4.2 Asia Intravenous Nutritional Product Revenue by Application (2026-2031)
11.5 Asia Intravenous Nutritional Product Revenue Share by Application (2020-2031)
11.6 Asia Intravenous Nutritional Product Revenue by Country
11.6.1 Asia Intravenous Nutritional Product Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Intravenous Nutritional Product Revenue by Country (2020-2025)
11.6.3 Asia Intravenous Nutritional Product Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Intravenous Nutritional Product Revenue (2020-2031)
12.2 SAMEA Intravenous Nutritional Product Revenue by Type (2020-2031)
12.2.1 SAMEA Intravenous Nutritional Product Revenue by Type (2020-2025)
12.2.2 SAMEA Intravenous Nutritional Product Revenue by Type (2026-2031)
12.3 SAMEA Intravenous Nutritional Product Revenue Share by Type (2020-2031)
12.4 SAMEA Intravenous Nutritional Product Revenue by Application (2020-2031)
12.4.1 SAMEA Intravenous Nutritional Product Revenue by Application (2020-2025)
12.4.2 SAMEA Intravenous Nutritional Product Revenue by Application (2026-2031)
12.5 SAMEA Intravenous Nutritional Product Revenue Share by Application (2020-2031)
12.6 SAMEA Intravenous Nutritional Product Revenue by Country
12.6.1 SAMEA Intravenous Nutritional Product Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Intravenous Nutritional Product Revenue by Country (2020-2025)
12.6.3 SAMEA Intravenous Nutritional Product Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.